Drug Type Biosimilar, Enzyme |
Synonyms MiRel, Reteplase biosimilar + [1] |
Target |
Mechanism PLG stimulants(Plasminogen stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date IN (01 Jan 2009), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Myocardial Infarction | IN | 01 Jan 2009 |